FDA Methitest / Android prescribing information
FDA / Pfizer
Orally taken, modified testosterone steroid; a medicine for hormone deficiency, but it puts heavy strain on the liver; banned in sport.

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

DETAILED OVERVIEW
Methyltestosterone is a modified version of testosterone that can be taken by mouth, the first steroid of this kind, known since 1935. In the United States it was approved as a prescription medicine to treat male hypogonadism, a lack of sex hormones (sold as Android, Methitest and Testred); it is not registered in Hungary or Poland. In bodybuilding it is now considered obsolete.
The modification puts heavy strain on the liver: it can cause cholestatic liver damage (with blocked bile flow) and jaundice, and with long use a risk of liver tumors; together with alcohol, paracetamol or other liver-harming substances it can even be fatal. It also converts into an estrogen, and the substance formed has a stronger estrogen effect than usual, so enlarged male breast tissue and water retention are common. It worsens cholesterol values and shuts down the body's own testosterone production; in women it causes partly irreversible masculinization, and it must not be used in pregnancy. WADA bans it year-round.
Mechanism
Androgen receptor stimulator; works by mouth; converts to estrogen
Anabolic:Androgenic
100:50
Half-life
4 hours (oral)
Onset
1 h (oral, sublingual too)
Legal status
FDA Rx (Android, Methitest, Testred), Schedule III
No anecdote collected yet.
Data console
FDA / Pfizer . FDA Methitest / Android prescribing information. DailyMed NDA 80-070 (methyltestosterone label).
Westaby D, Ogle SJ, Paradinas FJ, Randell JB, Murray-Lyon IM. . Liver damage from long-term methyltestosterone. Lancet. 1977;2(8032):262-3..
Yesalis CE, Streit AL, Vicary JR, Friedl KE, Brannon D, Buckley W. . Anabolic steroid use: indications of habituation among adolescents. J Drug Educ. 1989;19(2):103-16..
Pope HG Jr, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S. . Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014;35(3):341-75..
Hartgens F, Kuipers H. . Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004;34(8):513-554..
Safety
Side effects · 7
Contraindications · 7
Related Performance Compounds
Studies
FDA / Pfizer
Westaby D, Ogle SJ, Paradinas FJ, Randell JB, Murray-Lyon IM.
Yesalis CE, Streit AL, Vicary JR, Friedl KE, Brannon D, Buckley W.
Pope HG Jr, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S.
Hartgens F, Kuipers H.
Telegram
Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.
Personalized consultation
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.